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Abstract
Introduction The possibility of recanalization and the need
for retreatment are the most important limitations of intra-
cranial aneurysm embolization. The purpose of the study
was to compare the size of aneurysm remnants measured at
follow-up with three-dimensional digital subtracted angiog-
raphy (3D-DSA) and magnetic resonance angiography
(MRA).
Methods Twenty-six aneurysms were found incompletely oc-
cluded in 72 consecutively examined patients at a follow-up
after 3 months. The diameters and volume of aneurysm rem-
nants were compared between 3D-DSA, time-of-flight MRA
(TOF-MRA), contrast-enhanced TOF-MRA (CE-TOF-
MRA), and contrast-enhanced MRA (CE-MRA) at 1.5 T.
Results There was a significant correlation between remnant
volumes calculated based on 3D-DSA and all MRA modali-
ties. The intraobserver variability of the measurements ranged
from 3.4 to 4.1 % and the interobserver variability from 5.8 to
7.3 %. There were no significant differences in the variability
between the techniques. The mean residual filling volume
ranged from 16.3±19.0 mm3 in TOF-MRA to 30.5±
44.6 mm3 in 3D-DSA (P<0.04). Significant differences were
found in the volumes measured with 3D-DSA and CE-MRA
as compared to TOF-MRA and CE-TOF-MRA (P<0.01).
There was a moderate significant correlation between the
residual filling and the relative error of measurement in the
case of TOF-MRA and CE-TOF-MRA.
Conclusions TOF-MRA seems to underestimate the size of
aneurysm remnants detected at follow-up and should not be
used as a sole imaging method to decide on re-embolization.
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Introduction
Endovascular embolization has become a common method
for the treatment of intracranial aneurysms in many centers
of the USA and Europe [1, 2]. However, coiled aneurysms
present a significant rate of recanalization, which occurs in
approximately 20 % of patients [3, 4]. Due to the possibility
of recanalization and the availability of a relatively safe
endovascular retreatment [5], follow-up of coiled aneurysms
is recommended [6, 7].
For many years, digital subtracted angiography (DSA)
has been a method of choice for the follow-up of coiled
aneurysms. However, several recent studies have proven a
high diagnostic performance of magnetic resonance angiog-
raphy (MRA) in detecting the incomplete aneurysm occlu-
sion [8–15]. Therefore, due to a low invasiveness and a
relatively low cost, MRA has been proposed as the first-
choice modality for routine follow-up [16]. On the other
hand, the question whether time-of-flight MRA (TOF-
MRA) or contrast-enhanced MRA (CE-MRA) is a better
method for the imaging of coiled aneurysms remains unre-
solved. In fact, both techniques present similar specificity and
sensitivity in detecting the incomplete occlusion [8, 10], but
CE-MRA offers better imaging of large aneurysm remnants
and stented segments [9, 17].
Theses of this paper were presented at the European Congress of
Radiology 2012, Vienna, Austria.
Z. Serafin (*) : P. Strześniewski :W. Lasek
Department of Radiology and Diagnostic Imaging,
Collegium Medicum, Nicolaus Copernicus University,




Faculty of Health Sciences, University of Humanities




Apart from detecting the incomplete aneurysm occlusion,
follow-up imaging also aims at measuring the aneurysm rem-
nant since the size of residual filling volume is the most impor-
tant factor that determines the possibility of re-embolization [4].
However, technical differences between TOF-MRA and CE-
MRA raise a question of the accuracy of residual volume
measurements with these modalities. TOF-MRA is a flow-
detecting modality which highlights blood flowing in limited
directions above a threshold of velocity. Therefore, TOF-MRA
may be unable to properly detect the actual volume of the
residual aneurysm because of significant blood flow turbulence
within the coil mesh.
The purpose of the study was to test the hypothesis that
TOF-MRA is inadequate for measuring the residual filling
volume in the embolized aneurysms and therefore should not
be used for planning retreatment. Therefore, we compared the
volume of the residual filling in the coiled aneurysms mea-
sured at follow-up with the use of three-dimensional DSA




The study was based on a population of patients that partic-
ipated in a prospective single-center study on the diagnostic
value of DSA and MRA in the follow-up of ruptured intra-
cranial aneurysms [17]. The study was approved by the
university institutional review board. All participants pro-
vided written informed consent.
Between November 2009 and March 2011, a total num-
ber of 72 patients (24 men; mean age, 51.5±12.4 years) with
72 aneurysms were prospectively included in the study.
Those patients were scheduled for the first follow-up imag-
ing at 3 months after endovascular treatment for subarach-
noid hemorrhage caused by aneurysm rupture. Patients were
excluded for the following reasons: (a) age under 18 years;
(b) contraindications to MR imaging, including severe
claustrophobia, ferromagnetic foreign bodies, or electronic
implants; (c) the presence of neurosurgical clips; and (d)
estimated glomerular filtration rate <60 mL/min per
1.73 m2. At the end of all the embolizations, the baseline
status of the aneurysm was documented by two-dimensional
DSA (2D-DSA) and 3D-DSA.
Follow-up DSA technique
DSA was performed using a monoplane angiographic unit
(Axiom Artis dTA, Siemens Medical Systems, Erlangen,
Germany) by means of transfemoral catheterization. Iodin-
ated contrast material (iopromide, Ultravist 300 mg-I/mL,
Bayer Schering Pharma AG, Berlin, Germany) was admin-
istrated with a power injector through a 5-F catheter. The
examination consisted of a four-vessel 2D-DSA and 3D-
DSA of the aneurysm parent artery. The 3D-DSA imaging
was based on rotational acquisitions, covering 200°, result-
ing in 122 two-dimensional source images in cine mode.
The contrast agent was administered at a volume of 15 mL
(5 mL/s) to carotid arteries and 8 mL (3 mL/s) to vertebral
arteries. Images were analyzed on a dedicated workstation
(Syngo XVP VA72B, Siemens AG, Berlin, Germany) using
InSpace 3D software. Measurements were calibrated to the
diameter of the diagnostic catheter. The following recon-
struction parameters were used: voxel size, 0.57 mm; num-
ber of slices, 220; slice matrix, 512×512; kernel type, EE;
reconstruction mode, MIP; and dual volume.
Follow-up MRA technique
MR angiography was performed with a 1.5-T Signa HDx
unit using an eight-channel HD Brain Coil (GE Medical
Systems, Waukesha, WI, USA) within 24 h after DSA.
The examination consisted of three acquisitions: TOF-
MRA, CE-TOF-MRA, and CE-MRA. TOF-MRA was per-
formed with a 3D TOF ASSET Multislab technique (TE0
2.7 ms; TR030 ms; flip angle, 20°; bandwidth, 31.25 kHz;
effective voxel size, 0.7×0.8×0.6 mm). The same scanner
settings were used for CE-TOF-MRA, which was carried
out after a manual intravenous injection of 3 mL of
gadobenate dimeglumine (Gd-BOPTA; 0.5 mmol/mL, Mul-
tiHance, Bracco Imaging Deutschland GmbH, Konstanz,
Germany). The examination was completed with CE-MRA
(TE01.5 ms; TR03.5 ms; flip angle, 25°; bandwidth,
83.33 kHz; effective voxel size, 0.8×0.9×1.1 mm) after
power injection of 0.1 mmol/kg b.w. of Gd-BOPTA at
2 mL/s followed by saline flush.
Angiograms were evaluated with Advantage Workstation
4.4 and Volume Share 8.4.3 software (GE Medical Sys-
tems). The analysis included non-reconstructed images as
well as MPR, MIP, and VR reconstructions.
Image analysis
Examinations of all patients were anonymized and divided
into separate sets of 3D-DSA, TOF-MRA, CE-TOF-MRA,
and CE-MRA images, which were randomly coded in a
dedicated PACS folder.
The size of aneurysm remnants was compared between
3D-DSA, TOF-MRA, CE-TOF-MRA, and CE-MRA in
patients who presented the filling in all the examined mo-
dalities. The presence of the residual filling was any leakage
of contrast medium into the aneurysm neck or the aneurysm
sac (class 2 or 3 according to [18]). Two interventional
neuroradiologists (Z.S, P.S.) with a 10-year experience in
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the field independently assessed the blinded examinations,
being unaware of other imaging results of the patients. The
mean value of measurements performed by both investigators
was used as a measurement result. By comparing the results
presented by both observers, the inter-observer variability was
calculated. One investigator (Z.S.) performed a second
blinded analysis to calculate the intraobserver variability of
the results.
Three perpendicular dimensions (a, b, c) were measured
on MIP reconstructions to determine the flow volume
according to the formula for ellipsoid (v04/3×π×a×b×c).
Additionally, the comparison included the largest dimen-
sions which are common indicators of flow progression
and the smallest dimensions which determine the possibility
of retreatment.
Statistical analysis
The diameters and volumes were expressed as the mean
values±SD. The normality of the data was tested with the
Shapiro–Wilk test. The intraobserver and interobserver var-
iabilities of the measurements were calculated as follows:
var02×|x−y|/(x+y)×100 %, where x and y are the results of
repeated measurements. The significance of the differences
between the tested methods was tested with ANOVA for
repeated measures and then with Wilcoxon signed-rank test
for a direct comparison between methods.
Further analysis of the MRA modalities was related to the
residual filling volume and was carried out with an assump-
tion that 3D-DSA was a reference method. The relation
between the DSA and MRA results was determined using
a Pearson correlation coefficient (rv). The differences be-
tween the residual filling volume detected on 3D-DSA
images and on TOF-MRA, CE-TOF-MRA, and CE-MRA
images were given as a relative error: ev02×|VDSA−Vx|/
(VDSA+Vx)×100 %, where VDSA is the volume measured
on the 3D-DSA image and Vx is the volume detected with
the tested MRA method. A possible influence of the size of
residual filling on the relative error was tested using Pear-
son’s correlation coefficient (re). For this purpose, 3D-DSA
filling volume values were natural log-transformed to re-
duce unilateral skewness of the data.
A P value<0.05 was considered significant. Statistical
analyses were performed using MedCalc 11.6.0 (MedCalc
Software, Mariakerke, Belgium) and Statistica 9 (StatSoft
Inc., Tulsa, OK, USA).
Results
Follow-up examinations revealed residual flow in 26 aneur-
ysms (36.1 %, Table 1). All the patients who presented
incomplete occlusion had embolization performed with a
combination of bare platinum coils (GDC Detachable Coils,
Boston Scientific, Natick, MA; Axium and Nexus, ev3
Corporate, Plymouth, MN; MicroPlex, MicroVention, Inc.,
Tustin, CA) and hydrogel coils (HydroCoil and HydroSoft,
MicroVention). Neither balloon remodeling nor stent assis-
tance was used for these procedures.
The aneurysm remnants were classified as class 2 (resid-
ual neck) in eight cases and as class 3 (residual aneurysm) in
18 cases (Fig. 1). Compared to the initial results of emboli-
zation, recanalization of a totally occluded aneurysm was
noted in 18 cases: class 2 in seven patients and class 3 in 11
patients. The progression of residual filling from class 2 to
class 3 was observed in seven cases. There was also one
stable aneurysm of class 2. Measurement of the flow area
with the four tested angiographic methods gave significantly
different results (ANOVA: P<0.04; Table 2 and Fig. 2). The
measures determined with the use of 3D-DSA and CE-MRA
were significantly higher than those with TOF-MRA and
CE-TOF-MRA (Wilcoxon signed-rank test: P<0.01;
Fig. 3). Follow-up DSA resulted in a decision for retreat-
ment in 12 patients. A respective analysis of MRA images
allowed for a positive decision on re-embolization in nine
patients based on TOF-MRA and CE-TOF-MRA and in 11
patients based on CE-MRA. The most definite differences
were seen in the case of large aneurysm remnants (Fig. 4).
Intra-observer variability of the measurement was low,
Table 1 Baseline characteristics of the included patients with percentages
in parentheses
Characteristics Value (%)




Largest aneurysm diameter Small (≤5 mm) 7 (26.9)
Medium (5.1–15 mm) 16 (61.5)
Large (15.1–25 mm) 3 (11.5)
Giant (>25 mm) 0 (0.0)
Sack-to-neck ratio ≤1.5 13 (50.0)
1.6–2.5 11 (42.3)
>2.5 2 (7.7)
Number of coils placed ≤3 9 (34.6)
4–6 8 (30.8)
>6 9 (34.6)
Result of embolizationa Class 1 18 (69.2)
Class 2 8 (30.8)
Class 3 0 (0.0)
The assessment of the result of embolization was performed with 2D-
DSA and 3D-DSA, while all the measurements were based on 3D-
DSA
aAccording to Roy et al. [18]
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ranging from 3.4 to 4.1 %. Inter-observer variability ranged
from 5.8 to 7.3 %. There were no significant differences in
the variability between the techniques.
There was a significant correlation between the residual
filling volume calculated based on 3D-DSA and all MRA
modalities (P<0.001). The highest correlation was noted be-
tween 3D-DSA and CE-MRA (0.95; Table 3). Correspond-
ingly, CE-MRA had the lowest mean relative error of volume
measurement, while TOF-MRA and CE-TOF-MRA pre-
sented similar values (Table 3). There was a moderately
significant correlation between the residual filling volume
and the relative error of measurement in the case of TOF-
MRA and CE-TOF-MRA (Table 3 and Fig. 5).
Discussion
According to our knowledge, this is the first clinical study to
confirm that TOF-MRA at 1.5 T is inadequate for measuring
aneurysm remnants. We found that the size of residual
filling space measured with TOF-MRA and CE-TOF-
MRA was significantly smaller than that measured with
3D-DSA and CE-MRA. These differences were most pro-
nounced in the case of large aneurysm remnants.
In a recent study by Daugherty et al. [19], a significant
variability among experienced operators was demonstrated
when deciding whether a series of aneurysms should be
retreated. The inter-reader discrepancies, which might have
been substantial for patient management, were found in as
many as 63 % of cases. Therefore, there is a need for strict
criteria for the decision making on retreatment. One of such
parameters may be the size of the residual flow area of at least
2 mm, which provides an appropriate space for an additional
placement of the smallest coils [4]. Other proposed indications
for retreatment include growth of an aneurysm remnant
caused by coil loosening or coil compaction with unchanged
aneurysm boundaries and aneurysm regrowth in increasing
boundaries compared with the initial aneurysm size [20, 21].
However, with the use of a contemporary reference method of
cerebral vessel imaging, i.e., 2D-DSA, a precise measurement
of the aneurysm remnant is not an obvious issue. Despite the
significant advantages of the DSA technology, it still offers
linear measurements in pixels, not in millimeters, and requires
calibration [22]. Therefore, precise measurements on 2D-DSA
images require calibration on fiducial markers or diagnostic
catheters. Another solution is the use of 3D-DSA, which has a
finite isocenter and acquisition geometry, similar to those in
CT and MR imaging that provide measurements in “real”
millimeters [22].
Several studies proved the high diagnostic value of MRA
in detecting aneurysm remnants; therefore, in many centers,
MRA has become a first-line follow-up method after
Fig. 1 Residual aneurysm
(arrows) of the left internal
carotid artery presented on MIP
reconstructions of 3D-DSA (a),
TOF-MRA (b), CE-TOF-MRA
(c), and CE-MRA (d)
Table 2 Comparison of the largest diameter, the lowest diameter, and








3D-DSA 5.08 (±2.80) 2.26 (±0.97) 30.5 (±44.6)
TOF-MRA 3.73 (±2.09) 2.08 (±0.75) 16.3 (±19.0)
CE-TOF-
MRA
3.86 (±2.21) 2.18 (±0.86) 17.4 (±22.5)
CE-MRA 4.36 (±2.42) 2.30 (±0.94) 26.8 (±41.7)
Fig. 2 Mean volumes of aneurysm remnants with their 95% confi-
dence intervals as measured on 3D-DSA, TOF-MRA, CE-TOF-MRA,
and CE-MRA images
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aneurysm embolization [8–15]. Once an aneurysm remnant
is detected, it must be measured to determine possible
progression and to decide on the need for retreatment.
However, according to our results, the choice of follow-up
method is essential. We found that the residual flow volume
determined with the use of 3D-DSA and CE-MRA was
significantly higher than those with TOF-MRA and CE-
TOF-MRA. The mean volume of the flow area measured
with the use of TOF-MRAwas 87 % lower than in 3D-DSA
and 64 % lower than in CE-MRA. Three-dimensional DSA
is considered a method of choice for the detection, analysis,
and planning of endovascular aneurysm therapy [17, 23]. It
may also be considered the most precise modality of flow
quantification since coils are selected for embolization
Fig. 3 Direct comparison of
the residual flow volume
measured with 3D-DSA,
TOF-MRA, CE-TOF-MRA,
and CE-MRA in particular
aneurysms
Fig. 4 A case of recanalization
of the right internal carotid
artery aneurysm. The aneurysm
remnant (arrows) has different
sizes in 3D-DSA (a), TOF-
MRA (b), CE-TOF-MRA (c),
and CE-MRA (d)
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based on 3D-DSA images without a need for any additional
calibration. Thus, although TOF-MRA seems to be an ac-
curate method for the detection of residual flow, it may not
be considered a reliable method for flow quantification and
for decision making on retreatment, which is a more impor-
tant outcome of follow-up imaging.
The nature of TOF-MRAwhich detects blood flowing in
limited directions above a threshold of velocity provides an
explanation of the possible differences in filling volume
quantification between the tested modalities. Therefore,
TOF-MRA suffers signal loss in areas of slow and turbulent
flow due to intravoxel dephasing and spin saturation [9].
The signal-loss effect may explain more evident differences
in the volume of the aneurysm remnant in large-flow areas,
as observed in our study. Moreover, the addition of a small
amount of contrast medium during TOF-MRA acquisition
did not result in a significant improvement of flow measure-
ments. This indicates that the underestimation of the aneu-
rysm remnant size in TOF-MRA is related to the time-of-
flight technique itself rather than to the signal intensity.
Although our results are quite obvious from the technical
point of view, they seem to influence clinical practice sig-
nificantly. If TOF-MRA replaces DSA as a standard method
of follow-up to detect aneurysm incomplete occlusion, as
proposed by several authors [16, 24, 25], in the case of
positive results, it should be followed with CE-MRA or
3D-DSA to decide on possible retreatment.
There are limitations to this study that should be
addressed. Firstly, the sample size was calculated for a
different study that was aimed at determining the diagnostic
value of DSA and MRA in the follow-up of intracranial
aneurysms, and the 26 remnants found may be considered
inadequate. Nevertheless, the presented differences in the
residual flow size between the studied angiographic meth-
ods are statistically significant. Secondly, some measure-
ment errors related to the 3D-DSA image reconstruction
might have influenced our results because the flow size
was dependent on individual window adjustment to some
extent. However, the values of intra-observer and inter-
observer variability were relatively low and did not differ
significantly between the techniques. Moreover, none of our
imaging methods was calibrated using dedicated phantoms.
The study was designed to approach clinical practice, where
the precision of measurements depends on the internal cal-
ibration of imaging devices and is controlled by routine
quality assurance procedures. Finally, the study was per-
formed with the use of a 1.5-T scanner. Application of a
state-of-the-art 3-T system may provide different results
because of the increased signal-to-noise ratio, spatial reso-
lution, and contrast resolution [9].
Conclusion
We found that in our limited patient population, the size of
residual filling space in the embolized aneurysms measured at
follow-upwith 3D-DSA and CE-MRAwas significantly higher
than in TOF-MRA or CE-TOF-MRA. Therefore, in our opin-
ion, TOF-MRA and CE-TOF-MRA may underestimate the
Table 3 Analysis of the relation between the volume of aneurysm
remnants measured with 3D-DSA and the three tested MRA methods
rv ev (%) re
TOF-MRA 0.83 58.8 (±41.6) 0.50b
CE-TOF-MRA 0.69 54.7 (±46.9) 0.55b
CE-MRA 0.95 35.4 (±30.9)a 0.25
The relation is expressed as volume correlation (rv), relative error of
volume measurement (ev), and correlation between the reference vol-
ume and relative error (re)
a Significantly different from TOF-MRA and CE-TOF-MRA (P<0.05)
b Statistically significant (P<0.05)
Fig. 5 Relation between the
volume of aneurysm remnants
measured with 3D-DSA and the
relative error of volume mea-
surement with TOF-MRA, CE-
TOF-MRA, and CE-MRA.
Aneurysm remnant volumes
were natural log-transformed in
order to reduce unilateral
skewness of the data
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size of the residual flow. In concordance with several previous
reports, we still consider TOF-MRA as a first-line modality for
follow-up to detect the aneurysm recurrence mainly because of
its low invasiveness and the limited rate of aneurysm retreat-
ment. However, once the recurrence is found, we suggest
referring to CE-MRA of 3D-DSA to quantify the filling space,
while a definite decision on re-embolization may be made
based on 3D-DSA. The design of the study did not allow for
the investigation of possible sources of the observed differ-
ences. Future research based on a larger patient population
should be performed using automatic aneurysm segmentation
and analysis systems, which have been proposed for both the
3D-DSA [26] and MRA [27].
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